ARCH Venture Partners XII, LLC's Net Worth

$478 Million

Estimate Recalculated Feb 27, 2024 09:37AM EST

Who is ARCH Venture Partners XII, LLC?

ARCH Venture Partners XII, LLC has an estimated net worth of $478 Million. This is based on reported shares in Neumora Therapeutics, Inc..

SEC CIK

ARCH Venture Partners XII, LLC's CIK is 0001979548

Past Insider Trading and Trends

2023 was ARCH Venture Partners XII, LLC's most active year for acquiring shares with 24 total transactions. ARCH Venture Partners XII, LLC's most active month to acquire stocks was the month of August. 2023 was ARCH Venture Partners XII, LLC's most active year for disposing of shares, totalling 5 transactions. ARCH Venture Partners XII, LLC's most active month to dispose stocks was the month of August. 2023 saw ARCH Venture Partners XII, LLC paying a total of $31,430,024.08 for 19,431,768 shares, this is the most they've acquired in one year. In 2023 ARCH Venture Partners XII, LLC cashed out on 17,424,704 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Neumora Therapeutics, Inc. (NMRA) Snapshot price: $16.96

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+102.76%
1.88M
3.71M
Dec 8
Form 4
+0.85%
35.01K
$11.77
$412,139.61
4.13M
Nov 13 - Nov 14
Form 4
+3.55%
140.6K
$10.98
$1,543,563.42
4.1M
Nov 8 - Nov 10
Form 4
+2.48%
95.69K
$11.49
$1,099,944.70
3.96M
Nov 3 - Nov 7
Form 4
+2.02%
76.51K
$13.68
$1,046,848.16
3.86M
Sep 28 - Sep 29
Form 4
+1.57%
58.5K
$11.97
$700,464.24
3.78M
Sep 26 - Sep 27
Form 4
+2.78%
100.74K
$11.19
$1,127,063.95
3.72M
Sep 22 - Sep 25
Form 4
+178.19%
18.92M
$17.00
29.55M
Sep 19
Form 3
0
0
No matching records found

Prime Medicine, Inc. (PRME) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.2M
$6.25
$20,000,000.00
3.2M
Feb 15
No matching records found